- Home
- KRYS vs TENB Comparison
KRYS vs TENB Comparison
Compare KRYS & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- TENB
- Stock Information
- Founded
- KRYS 2015
- TENB 2002
- Country
- KRYS United States
- TENB United States
- Employees
- KRYS N/A
- TENB N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- TENB Computer Software: Prepackaged Software
- Sector
- KRYS Health Care
- TENB Technology
- Exchange
- KRYS Nasdaq
- TENB Nasdaq
- Market Cap
- KRYS 4.3B
- TENB 3.6B
- IPO Year
- KRYS 2017
- TENB 2018
- Fundamental
- Price
- KRYS $156.11
- TENB $30.06
- Analyst Decision
- KRYS Strong Buy
- TENB Buy
- Analyst Count
- KRYS 9
- TENB 17
- Target Price
- KRYS $203.22
- TENB $41.06
- AVG Volume (30 Days)
- KRYS 291.1K
- TENB 1.3M
- Earning Date
- KRYS 11-03-2025
- TENB 10-29-2025
- Dividend Yield
- KRYS N/A
- TENB N/A
- EPS Growth
- KRYS 36.22
- TENB N/A
- EPS
- KRYS 4.91
- TENB N/A
- Revenue
- KRYS $359,205,000.00
- TENB $949,251,000.00
- Revenue This Year
- KRYS $34.33
- TENB $11.66
- Revenue Next Year
- KRYS $47.84
- TENB $7.86
- P/E Ratio
- KRYS $31.49
- TENB N/A
- Revenue Growth
- KRYS 116.08
- TENB 11.41
- 52 Week Low
- KRYS $122.80
- TENB $28.51
- 52 Week High
- KRYS $207.84
- TENB $45.45
- Technical
- Relative Strength Index (RSI)
- KRYS 60.39
- TENB 47.00
- Support Level
- KRYS $136.73
- TENB $29.77
- Resistance Level
- KRYS $157.96
- TENB $31.27
- Average True Range (ATR)
- KRYS 5.32
- TENB 0.74
- MACD
- KRYS 0.93
- TENB -0.03
- Stochastic Oscillator
- KRYS 92.02
- TENB 36.24
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.